ODM-207 in Patients With Advance Solid Tumours

NCT03035591 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: ODM-207

Sponsor

Orion Corporation, Orion Pharma